Trabectedin and Eribulin: Where Do They Fit in the Management of Soft Tissue Sarcoma? - Wikidata - awgldk - TriplyDB

Trabectedin and Eribulin: Where Do They Fit in the Management of Soft Tissue Sarcoma?

Trabectedin and Eribulin: Where Do They Fit in the Management of Soft Tissue Sarcoma?

http://www.wikidata.org/entity/Q38769613

about

Trabectedin and Eribulin: Where Do They Fit in the Management of Soft Tissue Sarcoma?

http://www.wikidata.org/entity/Q38769613

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Trabectedin and Eribulin: Where Do They Fit in the Management of Soft Tissue Sarcoma?

@en

type

label

Trabectedin and Eribulin: Where Do They Fit in the Management of Soft Tissue Sarcoma?

@en

prefLabel

Trabectedin and Eribulin: Where Do They Fit in the Management of Soft Tissue Sarcoma?

@en

P1433

Q38769613-B2F55094-AB1E-421E-ADFB-DDA837DB6298

P1476

Q38769613-9D006DA9-B0F7-4DA9-AA64-DBC9D02C345C

P2093

Q38769613-B9B0995D-C924-454D-A890-591DF08A0875

Q38769613-D90AE72F-A151-4E7D-84F8-51AD36B5727A

P2860

Q38769613-05A06810-39D5-46C7-9857-49994039EEC8

Q38769613-1503AF79-5CC9-4442-9C46-E03F95E4A0A7

Q38769613-22D33486-9E96-40C4-8C4E-5747C09630F5

Q38769613-25B3E398-F62A-4628-B963-924A8E9660B1

Q38769613-36C82EBE-D53A-4E98-9FA8-34CD33BB030C

Q38769613-4CFE1D4D-72FE-4062-A0C0-4236CEB3EDA1

Q38769613-4D25EA29-1A63-44B3-8A3C-DD5CF4186109

Q38769613-4EA4598C-4B0B-4848-BB42-9A3AEC7C94A2

Q38769613-63F4E5C1-3B98-485B-B440-71C52BF64847

Q38769613-6F8D8BA5-11BF-416C-A233-0936CC9C8798

P2888

Q38769613-036E7822-AB81-49DD-B3DE-551DF01256DC

P304

Q38769613-AFDAF105-6E48-41E2-B6B7-D2BEDDE66EBE

P31

Q38769613-FB368AB6-A3D7-4D8E-AA99-41DA913D3F76

P356

Q38769613-4F6F0BC1-C53C-4358-B040-3762155A85EC

P433

Q38769613-C9886FD8-223F-4FE5-AF36-707297A292F7

P478

Q38769613-FD478222-80C2-4C08-A6DD-637F9340E73F

P577

Q38769613-B2FB24A0-7D67-4CAB-A2D3-4FFA0A7D7B56

P6179

Q38769613-4D7B5483-CFFE-4F18-B4A3-ED8C52B8AD29

P698

Q38769613-A69AF86B-0FFF-4AE2-A76D-E8C63C5EE2F4

P356

S11864-017-0477-X

P1433

Current Treatment Options in Oncology

P1476

Trabectedin and Eribulin: Where Do They Fit in the Management of Soft Tissue Sarcoma?

@en

P2093

Ravin Ratan

http://www.w3.org/2001/XMLSchema#string

Shreyaskumar R Patel

http://www.w3.org/2001/XMLSchema#string

P2860

Ecteinascidin-743: a marine-derived compound in advanced, pretreated sarcoma patients--preliminary evidence of activity.

Phase I and pharmacokinetic study of ecteinascidin-743, a new marine compound, administered as a 24-hour continuous infusion in patients with solid tumors.

Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial.

Phase I and pharmacokinetic study of Yondelis (Ecteinascidin-743; ET-743) administered as an infusion over 1 h or 3 h every 21 days in patients with solid tumours.

Phase I combination study of trabectedin and doxorubicin in patients with soft-tissue sarcoma.

Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trial.

Randomized Phase II Study of Trabectedin and Doxorubicin Compared With Doxorubicin Alone as First-Line Treatment in Patients With Advanced Soft Tissue Sarcomas: A Spanish Group for Research on Sarcoma Study.

Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcomas of the uterus: a Gynecologic Oncology Group study.

Eribulin mesylate reduces tumor microenvironment abnormality by vascular remodeling in preclinical human breast cancer models

Phase II study of ET-743 in advanced soft tissue sarcomas: a European Organisation for the Research and Treatment of Cancer (EORTC) soft tissue and bone sarcoma group trial.

P2888

s11864-017-0477-x

P304

34

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11864-017-0477-X

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1085461807

http://www.w3.org/2001/XMLSchema#string

P698

28534249

http://www.w3.org/2001/XMLSchema#string